X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2621) 2621
Publication (189) 189
Book Review (59) 59
Book Chapter (14) 14
Conference Proceeding (9) 9
Book / eBook (6) 6
Magazine Article (6) 6
Reference (2) 2
Data Set (1) 1
Dissertation (1) 1
Newsletter (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-obesity agents - pharmacology (1699) 1699
animals (1610) 1610
humans (1552) 1552
index medicus (1490) 1490
obesity (1397) 1397
obesity - drug therapy (1319) 1319
anti-obesity agents - therapeutic use (1131) 1131
male (969) 969
pharmacology & pharmacy (861) 861
mice (857) 857
rats (528) 528
obesity - metabolism (474) 474
female (460) 460
chemistry, medicinal (413) 413
body weight - drug effects (379) 379
anti-obesity agents - chemistry (335) 335
anti-obesity agents - adverse effects (329) 329
plant extracts - pharmacology (320) 320
mice, inbred c57bl (319) 319
weight loss - drug effects (297) 297
endocrinology & metabolism (296) 296
anti-obesity agents - administration & dosage (283) 283
body weight (272) 272
adipocytes - drug effects (270) 270
weight loss (266) 266
adult (264) 264
nutrition & dietetics (260) 260
weight-loss (257) 257
obesity - physiopathology (253) 253
biochemistry & molecular biology (249) 249
3t3-l1 cells (245) 245
insulin-resistance (227) 227
eating - drug effects (221) 221
orlistat (220) 220
adipose tissue - drug effects (216) 216
food-intake (213) 213
dose-response relationship, drug (207) 207
diet (203) 203
obesity - prevention & control (202) 202
analysis (201) 201
middle aged (199) 199
adipogenesis - drug effects (193) 193
adipose-tissue (193) 193
insulin resistance (192) 192
research (190) 190
metabolism (188) 188
disease models, animal (187) 187
lipid metabolism - drug effects (184) 184
body-weight (183) 183
energy metabolism - drug effects (182) 182
anti-obesity (180) 180
hypoglycemic agents - pharmacology (179) 179
adipogenesis (176) 176
physiological aspects (174) 174
drug therapy (170) 170
diabetes (169) 169
adipocytes - metabolism (168) 168
health aspects (168) 168
treatment outcome (168) 168
rats, sprague-dawley (167) 167
leptin (166) 166
structure-activity relationship (165) 165
obesity - complications (164) 164
weight gain - drug effects (164) 164
adipose tissue - metabolism (161) 161
obesity - etiology (160) 160
diet, high-fat (156) 156
metabolic syndrome (156) 156
obesity - blood (154) 154
rats, wistar (154) 154
anti-obesity agents - chemical synthesis (153) 153
liver - drug effects (153) 153
food science & technology (151) 151
body mass index (150) 150
lactones - therapeutic use (150) 150
hypoglycemic agents - therapeutic use (148) 148
glucose (144) 144
diet, high-fat - adverse effects (142) 142
phytotherapy (141) 141
weight reducing preparations (141) 141
expression (140) 140
overweight (136) 136
sibutramine (136) 136
double-blind (135) 135
care and treatment (134) 134
ppar gamma - metabolism (133) 133
lactones - pharmacology (132) 132
liver - metabolism (132) 132
insulin (130) 130
rodents (128) 128
risk factors (127) 127
triglycerides - blood (126) 126
time factors (125) 125
drug design (123) 123
lipids (123) 123
plant extracts - therapeutic use (123) 123
lipids - blood (122) 122
anti-obesity agents - pharmacokinetics (121) 121
weight control (120) 120
drugs (119) 119
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2580) 2580
Japanese (55) 55
French (16) 16
German (13) 13
Chinese (10) 10
Spanish (7) 7
Hungarian (5) 5
Polish (5) 5
Russian (4) 4
Portuguese (3) 3
Czech (2) 2
Italian (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Phytochemistry, ISSN 0031-9422, 09/2015, Volume 117, pp. 554 - 568
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 11/2016, Volume 153, pp. 663 - 678
Tea has a long history of medicinal and dietary use. Tea polysaccharide (TPS) is regarded as one of the main bioactive constituents of tea and is beneficial... 
Extraction | Bioactivity | Future perspectives | Purification | Structure | Tea polysaccharide | PU-ERH TEA | DIABETIC MICE | POLYMER SCIENCE | CHEMICAL-CHARACTERIZATION | CHEMISTRY, ORGANIC | OOLONG TEA | VITRO ANTIOXIDANT ACTIVITY | ACIDIC POLYSACCHARIDE | CAMELLIA-SINENSIS FLOWER | ZIYANG GREEN TEA | ACTIVITY IN-VITRO | CHEMISTRY, APPLIED | WATER-SOLUBLE POLYSACCHARIDE | Camellia sinensis - chemistry | Plant Extracts - chemistry | Anti-Infective Agents - isolation & purification | Adjuvants, Immunologic - pharmacology | Antioxidants - chemistry | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Humans | Adjuvants, Immunologic - chemistry | Polysaccharides - isolation & purification | Anti-Infective Agents - chemistry | Polysaccharides - chemistry | Adjuvants, Immunologic - isolation & purification | Antineoplastic Agents, Phytogenic - chemistry | Plant Extracts - isolation & purification | Hypoglycemic Agents - chemistry | Antioxidants - pharmacology | Anti-Obesity Agents - isolation & purification | Polysaccharides - pharmacology | Hypoglycemic Agents - pharmacology | Hypoglycemic Agents - isolation & purification | Anti-Obesity Agents - chemistry | Animals | Antioxidants - isolation & purification | Chemical Fractionation | Antineoplastic Agents, Phytogenic - pharmacology | Anti-Obesity Agents - pharmacology | Tea - chemistry | Antineoplastic Agents, Phytogenic - isolation & purification | Polysaccharides | Polyphenols | Yuan (China) | Functional foods
Journal Article
Journal Article
Mini-Reviews in Medicinal Chemistry, ISSN 1389-5575, 2013, Volume 13, Issue 2, pp. 163 - 193
Objective: Piper has been used for long timelike condiment and food, but also in traditional medicine around of the world. This work resumes the available and... 
Pharmacological actions | Piperaceae | Complementary medicine | Phytochemical constituents | Piper | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | LIPID-PEROXIDATION | ALZHEIMERS-DISEASE | LARVICIDAL ACTIVITY | LUNG CARCINOGENESIS | ORAL SUPPLEMENTATION | B16F-10 MELANOMA-CELLS | IN-VITRO | pharmacological actions | complementary medicine | HEALTHY-VOLUNTEERS | phytochemical constituents | CYTOTOXIC PYRIDONE ALKALOIDS | Anti-Infective Agents - toxicity | Central Nervous System Agents - therapeutic use | Plant Extracts - chemistry | Plant Extracts - toxicity | Antioxidants - chemistry | Obesity - drug therapy | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Cardiovascular Diseases - drug therapy | Humans | Platelet Aggregation Inhibitors - toxicity | Anti-Obesity Agents - therapeutic use | Anti-Obesity Agents - toxicity | Anti-Infective Agents - chemistry | Anti-Inflammatory Agents - therapeutic use | Platelet Aggregation Inhibitors - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Alkaloids - toxicity | Alkaloids - pharmacology | Central Nervous System Agents - chemistry | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Anti-Infective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Cardiovascular Agents - toxicity | Antioxidants - pharmacology | Cognition Disorders - drug therapy | Piper - chemistry | Cardiovascular Agents - pharmacology | Neoplasms - drug therapy | Antineoplastic Agents, Phytogenic - toxicity | Antioxidants - toxicity | Cardiovascular Agents - therapeutic use | Anti-Obesity Agents - chemistry | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Central Nervous System Agents - pharmacology | Platelet Aggregation Inhibitors - chemistry | Alkaloids - therapeutic use | Antineoplastic Agents, Phytogenic - pharmacology | Anti-Obesity Agents - pharmacology | Plant Extracts - therapeutic use | Alkaloids - chemistry | Central Nervous System Agents - toxicity | Cardiovascular Agents - chemistry
Journal Article
Chinese Journal of Natural Medicines, ISSN 1875-5364, 05/2015, Volume 13, Issue 5, pp. 321 - 337
is a widely distributed perennial herb belonging to the Poaceae family and has been extensively consumed for its medicinal, cosmetic, and nutritional effects... 
Pharmacological effects | Cymbopogon citratus stapf | Phytochemistry | ANTIFUNGAL ACTIVITY | LEMONGRASS OIL | BENZODIAZEPINE-RECEPTOR | RICH ESSENTIAL OIL | ANTIBACTERIAL ACTIVITY | CAFFEIC ACID | INTEGRATIVE & COMPLEMENTARY MEDICINE | CHEMICAL-COMPOSITION | PHARMACOLOGY & PHARMACY | FREE-RADICAL SCAVENGERS | MEDICINAL-PLANTS | ANTIMICROBIAL ACTIVITY | Central Nervous System Agents - therapeutic use | Urological Agents - pharmacokinetics | Urological Agents - pharmacology | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Humans | Rats, Inbred F344 | Hematologic Agents - pharmacokinetics | Male | Oils, Volatile - pharmacology | Antineoplastic Agents - therapeutic use | Oils, Volatile - pharmacokinetics | Anti-Obesity Agents - therapeutic use | Central Nervous System Agents - pharmacokinetics | Oils, Volatile - therapeutic use | Anti-Obesity Agents - pharmacokinetics | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Hematologic Agents - pharmacology | Cymbopogon | Urological Agents - therapeutic use | Hypoglycemic Agents - therapeutic use | Hypoglycemic Agents - pharmacokinetics | Plant Oils - pharmacology | Anti-Inflammatory Agents - pharmacology | Hematologic Agents - therapeutic use | Anti-Infective Agents - therapeutic use | Antioxidants - pharmacology | Plant Oils - therapeutic use | Hypoglycemic Agents - pharmacology | Antioxidants - therapeutic use | Ethnopharmacology | Animals | Anti-Infective Agents - pharmacokinetics | Plant Extracts - pharmacokinetics | Central Nervous System Agents - pharmacology | Mice | Antioxidants - pharmacokinetics | Anti-Obesity Agents - pharmacology | Plant Extracts - therapeutic use | Plant Oils - pharmacokinetics
Journal Article
Obesity, ISSN 1930-7381, 05/2013, Volume 21, Issue 5, pp. 935 - 943
Objective: To examine the effects of naltrexone/bupropion (NB) combination therapy on weight and weight‐related risk factors in overweight and obese... 
NUTRITION & DIETETICS | METAANALYSIS | OVERWEIGHT | ENDOCRINOLOGY & METABOLISM | ADULTS | HYPERTENSION | BLOOD-PRESSURE | LIFE | Naltrexone - therapeutic use | Dopamine Uptake Inhibitors - adverse effects | Dyslipidemias - complications | Obesity - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Dopamine Uptake Inhibitors - therapeutic use | Anti-Obesity Agents - adverse effects | Male | Weight Loss - drug effects | Anti-Obesity Agents - therapeutic use | Overweight | Naltrexone - pharmacology | Adult | Female | Drug Therapy, Combination | Bupropion - adverse effects | Bupropion - therapeutic use | Cardiovascular Diseases - etiology | Dopamine Uptake Inhibitors - pharmacology | Double-Blind Method | Obesity - complications | Risk Factors | Narcotic Antagonists - adverse effects | Feeding Behavior - drug effects | Nausea - etiology | Narcotic Antagonists - therapeutic use | Narcotic Antagonists - pharmacology | Obesity - prevention & control | Hypertension - complications | Quality of Life | Bupropion - pharmacology | Naltrexone - adverse effects | Anti-Obesity Agents - pharmacology | Delayed-Action Preparations | Hypertension | Studies | Obesity | Medical research | Nutrition research | Weight control | Behavior | Diabetes | Drug dosages | Food | Quality of life | Clinical Trials | Behavior, Pharmacotherapy, Devices, Surgery
Journal Article